TATE and Pembrolizumab (MK3475) in mCRC and NSCLC
Phase 2 Recruiting
110 enrolled
Trial of AMB-05X for Patients With ctDNA(+) Colorectal Cancer After Curative-intent Treatment
Phase 2 Recruiting
15 enrolled
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
Phase 2 Recruiting
327 enrolled
AndroMETa-CRC
Phase 2 Recruiting
390 enrolled
An Investigational Drug (TPST-1495) in Patients With Familial Adenomatous Polyposis
Phase 2 Recruiting
38 enrolled
A Phase 2 Study of Zanidatamab in Patients With HER2-expressing Tumors
Phase 2 Recruiting
200 enrolled
Trial of 5-Fluorouracil (5FU)-Based Therapy in Combination With Fruquintinib in Patients With Locally Advanced Unresectable or Metastatic Colorectal Cancer
Phase 2 Recruiting
50 enrolled
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
Phase 2 Recruiting
90 enrolled
panSOHO
Phase 2 Recruiting
111 enrolled
A Phase II Study of Sintilimab Combined With Ipilimumab N01, Cetuximab and Dabrafenib in Patients With Microsatellite-Stable, BRAF V600E-Mutated Metastatic Colorectal Cancer
Phase 2 Recruiting
49 enrolled
A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
Phase 2 Recruiting
20 enrolled
CLOVER
Phase 2 Recruiting
60 enrolled
Liposomal Irinotecan With TAS102 and Bevacizumab for Patients With Metastatic Colorectal Cancer
Phase 2 Recruiting
50 enrolled
Flat Dose vs. Weight-based IP Chemotherapy for CRS/HIPEC
Phase 2 Recruiting
100 enrolled
Platform Study of Immunotherapy Combinations in Colorectal Cancer Liver Metastases
Phase 2 Recruiting
24 enrolled
Ph II Study of Enfortumab Vedotin in Patients With Advanced or Metastatic CRC or HCC
Phase 2 Recruiting
40 enrolled
An Evaluation of NGM120 in a Randomized, Double-blind, Placebo-controlled Study in Participants With Colorectal Cancer Who Have Cancer Cachexia.
Phase 2 Recruiting
136 enrolled
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Phase 2 Recruiting
20 enrolled
A Study to Evaluate the Safety and Efficacy of Two Dose Levels of ONO-4578 With Opdivo®, in Combination With mFOLFOX6 and Bevacizumab Versus Standard of Care in Participants With Non-MSI-H/dMMR, PD-L1 Positive Advanced Colorectal Cancer
Phase 2 Recruiting
144 enrolled
KN035 for dMMR/MSI-H Advanced Solid Tumors
Phase 2 Recruiting
200 enrolled
SCRT-CAPEOX-Serplulimab for MSS/pMMR Rectal Cancer With Oligometastases
Phase 2 Recruiting
51 enrolled
Neo-POLEM
Phase 2 Recruiting
44 enrolled
Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)
Phase 2 Recruiting
454 enrolled
FRUITFUL
Phase 2 Recruiting
60 enrolled
A Phase II Study of SHR-8068 Injection in Combination With Anti-tumor Therapies in Colorectal Cancer
Phase 2 Recruiting
200 enrolled
Cemiplimab With or Without Fianlimab to Treat Older Patients With Localized or Locally Advanced MSI-H Colorectal Cancer
Phase 2 Recruiting
44 enrolled
FRUITION
Phase 2 Recruiting
120 enrolled
MA-CRC-II-018
Phase 2 Recruiting
48 enrolled
DEL-LIVER
Phase 2 Recruiting
90 enrolled
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Phase 2 Recruiting
140 enrolled
Pre-operative Targeted Treatments in Molecularly Selected Resectable Colorectal Cancer (UNICORN)
Phase 2 Recruiting
197 enrolled
A Study of YL202 in Patients With Advanced Solid Tumors
Phase 2 Recruiting
100 enrolled
TAS-102 With or Without Celecoxib in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
Phase 2 Recruiting
25 enrolled
STAR
Phase 2 Recruiting
210 enrolled
PILDI
Phase 2 Recruiting
100 enrolled
Telehealth Intervention for Ostomy Self-Management
Phase 2 Recruiting
150 enrolled
Immunotherapy Using Tumor Infiltrating Lymphocytes for Patients With Metastatic Cancer
Phase 2 Recruiting
332 enrolled
Low-Dose Radiotherapy to Sensitize Pucotenlimab Plus CAPEOX for pMMR Locally Advanced Rectal Cancer
Phase 2 Recruiting
50 enrolled
Phase II Study of EMB-01 in Recurrent/Metastatic Colorectal Cancer Patients
Phase 2 Recruiting
54 enrolled
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Phase 2 Recruiting
24 enrolled
Avapritinib for the Treatment of CKIT or PDGFRA Mutation-Positive Locally Advanced or Metastatic Malignant Solid Tumors
Phase 2 Recruiting
50 enrolled
PDS01ADC in Combination With Hepatic Artery Infusion Pump (HAIP) and Systemic Therapy for Subjects With Metastatic Colorectal Cancer, Intrahepatic Cholangiocarcinoma, or Metastatic Adrenocortical Carcinoma
Phase 2 Recruiting
70 enrolled
A Study of Single Fraction Stereotactic Body Radiation Therapy (SBRT) Guided by Magnetic Resonance Imaging (MRI) in People With Liver Metastasis From Colorectal Cancer
Phase 2 Recruiting
32 enrolled
CHIMERA
Phase 2 Recruiting
42 enrolled
A Study To Evaluate The Efficacy And Safety Of Ifinatamab Deruxtecan (I-DXd) In Subjects With Recurrent Or Metastatic Solid Tumors (IDeate-PanTumor02)
Phase 2 Recruiting
520 enrolled
GSL Synthetase Inhibitor Plus Immune Checkpoint Inhibitor and/or Regorafenib in Previously Treated pMMR/MSS CRC.
Phase 2 Recruiting
120 enrolled
Addition of Antibiotics to Upfront Treatment Regimen for Colorectal Cancer
Phase 2 Recruiting
97 enrolled
Anlotinib Combined With Sintilimab as First-line Treatment for Advanced Non-liver Metastatic Colorectal Cancer
Phase 2 Recruiting
37 enrolled
A Study of Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy
Phase 2 Recruiting
284 enrolled
Comparative Study on the Short- and Long-term Efficacy of Q-ISR, Traditional Sub-ISR, and t-ISR
Phase 2 Recruiting
100 enrolled